Sofinnova Investments, Inc. Aerovate Therapeutics, Inc. Transaction History
Sofinnova Investments, Inc.
- $1.23 Billion
- Q4 2024
A detailed history of Sofinnova Investments, Inc. transactions in Aerovate Therapeutics, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 3,758,686 shares of AVTE stock, worth $8.98 Million. This represents 0.81% of its overall portfolio holdings.
Number of Shares
3,758,686
Previous 3,758,686
-0.0%
Holding current value
$8.98 Million
Previous $7.86 Million
26.8%
% of portfolio
0.81%
Previous 0.74%
Shares
1 transactions
Others Institutions Holding AVTE
# of Institutions
83Shares Held
30.7MCall Options Held
186KPut Options Held
269K-
Ra Capital Management, L.P. Boston, MA9.19MShares$22 Million0.39% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA2.24MShares$5.36 Million0.97% of portfolio
-
Atlas Venture Life Science Advisors, LLC1.8MShares$4.3 Million0.79% of portfolio
-
Braidwell LP Stamford, CT1.44MShares$3.44 Million0.21% of portfolio
-
Logos Global Management LP San Francisco, CA1.4MShares$3.35 Million0.49% of portfolio
About Aerovate Therapeutics, Inc.
- Ticker AVTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,448,100
- Market Cap $58.4M
- Description
- Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...